Marijuana has been studied by scientists for a larger part of our history as humans. Science is notorious for finding little to agree upon as much of science is based in a world of theory, and while to some a theory is seen as insane and maniacal in its birth, the study and potential for that science when theory becomes practice is enormous. What many scientists can currently agree on when it comes to Marijuana is the potential that the Cannabinoids in THC carry for clinical study. They agree that this potential is enormous and the implications within the scientific community could be endless. The scientific community believes that the study of THC could yield results for the treatments of pain and nerve injuries as well as an aide to those suffering with AIDS and Cancer.

But none of this matters sadly as there are still far too many regulations and attitudes surrounding the research many scientists would like to perform. Despite the research being legitimate and the implications in science and medicine huge, there is still far too much red tape to cut through and hoops that someone need jump through before a clinical study in THC can begin. Today, Marijuana is still labeled as a Schedule-1 Drug. What this means that it is seen in the law as being potentially addictive and having no medical use. This stigma is continuing in our own society as research grants are turned away when they specifically state that they want to study the medical benefits of Marijuana. When a grant is re-worded to state that it’s researching the negative effects of Marijuana it suddenly finds itself flush with funding.